Variant Bio
Focus: Variant Bio is a genomic drug discovery biotechnology company headquartered in Seattle focused on oncology. The company operates at pre-clinical/early-stage development with a highly specialized platform.
Profile data last refreshed 4h ago · AI intelligence enriched 3w ago
Open Jobs
2+1 this month
Stable — net +1 jobs in 30d
3 added, 2 removed. Backfill posture.
Should You Work at Variant Bio?
AI assessmentVariant Bio is a high-risk, high-science opportunity suitable only for scientists seeking platform development in early-stage genomics; limited immediate job availability and pre-clinical maturity make it unsuitable for those seeking rapid career progression or near-term exit liquidity.
Why Work Here
- Cutting-edge genomic drug discovery platform in oncology offers exposure to emerging therapeutic modality
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Variant Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.